Compare FBRX & RYAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FBRX | RYAM |
|---|---|---|
| Founded | N/A | 1926 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.4M | 422.1M |
| IPO Year | N/A | N/A |
| Metric | FBRX | RYAM |
|---|---|---|
| Price | $27.20 | $5.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $67.00 | $6.00 |
| AVG Volume (30 Days) | 165.7K | ★ 550.6K |
| Earning Date | 11-14-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,471,356,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.99 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.90 | $3.35 |
| 52 Week High | $31.27 | $8.56 |
| Indicator | FBRX | RYAM |
|---|---|---|
| Relative Strength Index (RSI) | 64.83 | 42.59 |
| Support Level | $24.79 | $5.59 |
| Resistance Level | $29.33 | $6.00 |
| Average True Range (ATR) | 3.02 | 0.20 |
| MACD | -0.07 | 0.02 |
| Stochastic Oscillator | 64.96 | 38.35 |
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
Rayonier Advanced Materials Inc is engaged in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, and High-Yield Pulp. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of its revenue from the United States.